Intricon Corp
NASDAQ:IIN
Intrinsic Value
Intricon Corp. engages in the design, development, engineering, manufacture, and distribution of miniature and micro-miniature body-worn devices. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of IIN.
Intricon Corp's market capitalization is 225.2m USD.
IIN stock price is 24.24 USD.
IIN.
IIN. Open DCF Valuation
IIN. Open Relative Valuation
IIN.
IIN's ROE (Return on Equity) has decreased in the last 3 years from 0% to -2%.
IIN's ROIC (Return on Invested Capital) has increased in the last 3 years from 0% to 2%.
IIN's Revenue has grown by 12% over the past 12 months.
IIN has negative Free Cash Flow for the last twelve months.
IIN's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 2%.
IIN's ROE (Return on Equity) for the past 12 months is negative and is equal to -2%.
IIN has positive Operating Income for the last twelve months.
IIN has positive Gross Profit for the last twelve months.
IIN has negative Net Income for the last twelve months.
IIN has a very low three-year average ROIC (Return on Invested Capital): 1%. The company is not efficient at using invested capital to generate operating income.
IIN has negative three-year average ROE (Return on Equity): -1%. The company is not efficient at transforming stockholders' equity into net income.
IIN's short-term assets (77m USD) exceed its short-term liabilties (24m USD).
IIN's long-term assets (127m USD) exceed its long-term liabilties (33m USD).
IIN's D/E (Debt to Equity) is very low and is equal to 0.
IIN's Altman Z-Score is very high and is equal to 5.3.
IIN earns more than enough operating income (2m USD) to safely cover interest payments on its debt (70k USD).
Fundamental Analysis
Intricon Corp
Balance Sheet Decomposition
Intricon Corp
| Current Assets | 76.6m |
| Cash & Short-Term Investments | 20.8m |
| Receivables | 23.7m |
| Other Current Assets | 32.2m |
| Non-Current Assets | 49.9m |
| Long-Term Investments | 5.2m |
| PP&E | 21.1m |
| Intangibles | 8.6m |
| Other Non-Current Assets | 15m |
| Current Liabilities | 24m |
| Accounts Payable | 13.3m |
| Accrued Liabilities | 10.2m |
| Other Current Liabilities | 420k |
| Non-Current Liabilities | 9m |
| Other Non-Current Liabilities | 9m |
Earnings Waterfall
Intricon Corp
|
Revenue
|
126.5m
USD
|
|
Cost of Revenue
|
-94.5m
USD
|
|
Gross Profit
|
32m
USD
|
|
Operating Expenses
|
-30.4m
USD
|
|
Operating Income
|
1.6m
USD
|
|
Other Expenses
|
-3.1m
USD
|
|
Net Income
|
-1.5m
USD
|
Free Cash Flow Analysis
Intricon Corp
What is Free Cash Flow?
IIN Profitability Score
Profitability Due Diligence
Intricon Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Intricon Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
IIN Solvency Score
Solvency Due Diligence
Intricon Corp's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
Intricon Corp's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IIN Price Targets Summary
Intricon Corp
Ownership
IIN Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
IIN Price
Intricon Corp
| Average Annual Return | -15.97% |
| Standard Deviation of Annual Returns | 20.58% |
| Max Drawdown | -63% |
| Market Capitalization | 225.2m USD |
| Shares Outstanding | 9 302 320 |
| Percentage of Shares Shorted | 1.89% |
Company Profile
Intricon Corp
Country
Industry
Market Cap
Dividend Yield
Description
Intricon Corp. engages in the design, development, engineering, manufacture, and distribution of miniature and micro-miniature body-worn devices. The company is headquartered in Arden Hills, Minnesota and currently employs 873 full-time employees. The firm serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micro medical devices components and subassemblies for medical markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. The company manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete catheter-based and body-worn devices for medical device manufacturers. The firm serves its market by offering medical device manufacturers, which have the capabilities to design, develop, manufacture, package and distribute medical devices. The company operates globally with facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.
You don't have any saved screeners yet
